DR. MAYKEN GORISSEN
0809.457.278 · rovalta.com · 25/09/2026
DR. MAYKEN GORISSEN
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODR. MAYKEN GORISSEN is a Private limited company incorporated in 2009. Its registered office is in Zedelgem.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0809.457.278
- Incorporation
- 29/01/2009
- Legal form
- Private limited company
- Registered office
- Kezelbergstraat 26
8210 Zedelgem · FlandreSee on map - Contributed capital
- 80 000,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 17 filingsTrend over 16 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 430,9 k € | -3.8% | 447,9 k € | +9.4% | 409,4 k € | +33.9% | 305,7 k € | -5.2% | 322,6 k € |
| EBITDA | 429,7 k € | -3.8% | 446,7 k € | +9.4% | 408,2 k € | +34.0% | 304,7 k € | -5.3% | 321,6 k € |
| Operating result | 426,2 k € | -4.0% | 444,1 k € | +15.3% | 385,2 k € | +36.6% | 281,9 k € | -5.7% | 299 k € |
| Net result | 305,8 k € | -1.7% | 311,2 k € | +20.3% | 258,7 k € | +75.7% | 147,2 k € | -29.8% | 209,7 k € |
| Balance sheet | |||||||||
| Equity | 1,7 M € | +6.3% | 1,6 M € | +11.1% | 1,5 M € | +8.5% | 1,4 M € | +1.1% | 1,3 M € |
| Total assets | 2,3 M € | +15.4% | 2 M € | +17.5% | 1,7 M € | +20.1% | 1,4 M € | +0.6% | 1,4 M € |
| Cash | 392,5 k € | +135% | 166,7 k € | +43.0% | 116,6 k € | -75.8% | 482,4 k € | -32.3% | 713 k € |
| Debts | 564,5 k € | +53.5% | 367,8 k € | +51.2% | 243,3 k € | +226% | 74,6 k € | -4.3% | 78 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 4 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 26/06/2026 | 23/06/2025 | 26/07/2024 | 16/06/2023 | 09/06/2022 | 28/04/2021 |
| General meeting | 19/06/2026 | 18/06/2025 | 28/06/2024 | 07/06/2023 | 23/05/2022 | 22/04/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 17 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 19/06/2026 | 26/06/2026 | Dutch | |
| Micro model | 31/12/2024 | 18/06/2025 | 23/06/2025 | Dutch | |
| Micro model | 31/12/2023 | 28/06/2024 | 26/07/2024 | Dutch | |
| Micro model | 31/12/2022 | 07/06/2023 | 16/06/2023 | Dutch | |
| Micro model | 31/12/2021 | 23/05/2022 | 09/06/2022 | Dutch | |
| Micro model | 31/12/2020 | 22/04/2021 | 28/04/2021 | Dutch | |
| Micro model | 31/12/2019 | 15/06/2020 | 30/06/2020 | Dutch | |
| Micro model | 31/12/2018 | 26/06/2019 | 27/06/2019 | Dutch | |
| Micro model | 31/12/2017 | 30/06/2018 | 31/07/2018 | Dutch | |
| Micro model | 31/12/2016 | 10/06/2017 | 20/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 01/06/2016 | 17/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 15/06/2015 | 19/06/2015 | Dutch | |
| Abridged model | 31/12/2013 | 28/06/2014 | 30/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 31/05/2013 | 21/06/2013 | Dutch | |
| Abridged model | 31/12/2011 | 14/05/2012 | 01/06/2012 | Dutch | |
| Abridged model | 31/12/2010 | 28/03/2011 | 28/04/2011 | Dutch | |
| Abridged model | 31/12/2009 | 03/07/2010 | 13/07/2010 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 4 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025305,8 k €↓
- 2024Annual accounts 2024311,2 k €↑
- 2023Annual accounts 2023258,7 k €↑
- 2022Annual accounts 2022147,2 k €↓
- 2021Annual accounts 2021209,7 k €↑
- 2021Name changeMAYKEN GORISSEN DR.
- 2020Annual accounts 2020172,2 k €↓
- 2019Annual accounts 2019203,6 k €↑
- 2018Annual accounts 2018152,4 k €↑
- 2017Annual accounts 2017147,3 k €↑
- 2016Annual accounts 201662 k €↓
- 2015Annual accounts 2015146,3 k €↑
- 2014Annual accounts 2014112,7 k €↓
- 2013Annual accounts 2013207,3 k €↑
- 2012Annual accounts 2012147,3 k €↑
- 2011Annual accounts 201191,6 k €↓
- 2010Annual accounts 2010134,1 k €
- 29/01/2009IncorporationPrivate limited company
- 2009Name changeDR. MAYKEN GORISSEN